They take drugs. They are sexually active. They are involved in violence. They are girls who are associated with gangs, and the perception from schools, state agencies and even families is that they are beyond help.
A study funded by the Wellcome Trust and aimed at developing a genetic map of Britain has begun to shed light on how the ancient populations of Britain ? the Celts, Anglo Saxons and Vikings ? moved into and across the country. Initial findings, presented in the Channel 4 series Face of Britain, support the notion that the Viking invasion of Britain was predominantly from Danish Vikings, with particularly Orkney being invaded by Norse Vikings.
Doctors need to take concerted action to ensure that people who are at risk of heart disease receive the influenza vaccine every autumn, according to the authors of a new report published in the European Heart Journal.
A type of omega-3 fatty acid may slow the growth of two brain lesions that are hallmarks of Alzheimer’s disease, UC Irvine scientists have discovered. The finding suggests that diets rich in docosahexaenoic acid (DHA) can help prevent the development of Alzheimer’s disease later in life.
The GlaxoSmithKline cervical cancer candidate vaccine, CERVARIX(R), demonstrated 100 percent efficacy in preventing precancerous lesions due to cancer-causing human papillomavirus types 16 and 18 for up to 5.5 years in an extended follow-up trial, according to data presented at the American Association for Cancer Research.
The American Australian Association (AAA) is proud to announce that Professor Ian Frazer, named Australian of the Year 2006 for his pivotal work on the human papilloma virus, will be the keynote speaker at Boston Biorelationships on Friday May 4, 2007.
Results of two studies funded by Project A.L.S. and appearing in today’s advance online publication of Nature Neuroscience demonstrate that embryonic stem cells may provide a new tool for studying disease mechanisms and for identifying drugs to slow ALS, also known as Lou Gehrig’s disease.
According to a study that appears in the April 17 issue of Neurology, researchers at the University of Pennsylvania School of Medicine have found that natalizumab (TYSABRI?) ? a drug that slows disability and reduces relapse rates in patients with multiple sclerosis (MS) ? also reduces vision loss in patients with relapsing MS.
Research has shown there is a connection between reproductive factors?such as age at first birth, number of births, and breastfeeding?and a woman?s risk of breast cancer.
A consortium of Canadian and American researchers report in Nature Genetics the results from a search of the entire human genome for genetic risk factors leading to the development of Crohn’s disease.